Table 2 Clinical details of patients used in this study.
Code | Size/Location of infarct | Age | Sex | Vascular risk factors | Immediate cause of death | Other disease | Stroke survival | Medications Statin/Anti-hypertensives |
|---|---|---|---|---|---|---|---|---|
I06-139 | R MCA stroke atherothrombotic (TACI)* | 84 | M | Smoking, HTA, MI, CAD, Stroke, PVD | Large stroke | CRF, AD stage II B&B | 5 days | Antiplatelets, Statins, Rasb |
A06-77 | L MCA stroke cardioembolic (TACI) | 75 | F | HTA, DM, CAD, stroke, valvulopathy, | Acute pulmonary edema | AD stage IIA B&B | 3 days | Antiplatelets, Statins, Rasb |
I06-232 | L MCA atherothrombotic stroke (PACI) | 75 | M | Smoking habit, alcoholism, hypercholesterolemia | Respiratory infection | Alcoholic liver disease, chronic obstructive pulmonary disease | 10 days | Statin |
I06-256 | R MCA stroke atherothrombotic (TACI) | 77 | M | Smoking habit, HTA, DM, atrial fibrillation | Large stroke, Respiratory infection | Colon adenocarcinoma | 52 days | Antiplatelets, Statins, Rasb |
I07-15 | L MCA stroke atherothrombotic (TACI) | 83 | M | HTA, hypercholesterolemia, CAD | Respiratory infection | no | 7 days | Statins, Rasb |
I07-30 | R MCA stroke atherothrombotic (TACI) | 89 | F | none | Acute pulonary edema, respiratory infection | no | 21 days | none |